12th Annual Non-Dilutive Funding Summit

  • 12th Annual Non-Dilutive Funding Summit

    Join life science industry leaders in San Francisco for a full day of non-dilutive funding activities
    January 11, 2017 – Marines’ Memorial Hotel – 609 Sutter Street, San Francisco

    Registration is Closed

Free Registration

  • About

    The Non-Dilutive Funding Summit is a free educational event that brings together hundreds of life science industry leaders to learn from various funding sources about their interests, goals and funding objectives.

    Attend presentations by the Defense Threat Reduction Agency (DTRA), the National Cancer Institute (NCI), the FreeMind Group experts and more!


8:00 – 8:30

Breakfast and Networking

8:00 – 8:30

Pre-conference Workshop

Guy Har-Chen
Chief Client Strategist, FreeMind Group

8:30 – 9:00

FreeMind Group Presentation

Ram May-Ron
Managing Partner, FreeMind Group

9:00 – 10:00

Defense Threat Reduction Agency (DTRA) Presentation

Keynote Address: Preparing for the Unthinkable

Dr. Ronald Hann
Director, Chemical and Biological Technologies Department, DTRA

10:00 – 10:30

BARDA’s CARB-X Presentation

CARB-X: A Novel Non-Dilutive Partnership to Promote Innovation and Foster a Robust Antimicrobials Pipeline

Tyler Merkeley

BARDA’s CARB-X Program Manager, Health Scientist, Division of CBRN Countermeasures, Biomedical Advanced Research and Development Authority (BARDA)

10:30 – 11:00

Greenberg Traurig, LLP Presentation

Legal Aspects of Federal Technology Investment and Their Potential Impact on Your Intended Markets

Paul F. McQuade
Shareholder; Co-Chair, Global Patent Prosecution Group

11:00 – 12:00

Round Table Discussions

Meet with Dr. Ronald Hann

Director, Chemical and Biological Technologies Department, DTRA

Meet With Tyler Merkeley

BARDA’s CARB-X Program Manager, Health Scientist, Division of CBRN Countermeasures, BARDA

12:00 – 1:00


Served in the main hall

1:00 – 1:30

Life Science Nation Presentation

Fundraising Bootcamp

Dennis Ford
Founder and CEO, Life Science Nation

1:30 – 2:00

National Cancer Institute (NCI) Presentation

The NCI SBIR Program: Structure, Funding Interests, and FAQs

Dr. Todd Haim
Program Director, SBIR Development Center, NCI

2:00 – 2:45

National Cancer Institute (NCI) Presentation

New Initiatives to Accelerate Development of Cancer Therapies in the Era of Precision Medicine

Dr. Margaret Mooney
Chief of the Clinical Investigations Branch (CIB) of the Cancer Therapy Evaluation Program (CTEP), Division of Cancer Treatment and Diagnosis, NCI

2:45 – 3:15

National Science Foundation (NSF) Presentation


Henry Ahn
Program Director, SBIR/STTR, Division of Industrial Innovation and Partnerships, NSF

3:15 – 3:30

Coffee Break

3:30 – 4:15

Round Table Discussions

Meet with Dr. Margaret Mooney

Chief of the Clinical Investigations Branch (CIB) of the Cancer Therapy Evaluation Program (CTEP), Division of Cancer Treatment and Diagnosis, NCI

Meet with Dr. Todd Haim

Program Director SBIR Development Center, NCI

Meet with Henry Ahn

Program Director, SBIR/STTR, Division of Industrial Innovation and Partnerships, NSF


Meeting Adjourns

See you next year!


  • Marines’ Memorial Club

    609 Sutter Street
    In the heart of San Francisco,
    a stone’s throw from all JPM activities!

Participating and Supporting Organizations

Who will attend?

C’ Level Life Science Executives
V’ Level Life Science Executives
Service Providers

Watch Videos from the 11th Annual NDFS

List of Attending Companies – 11th Annual NDFS

3-D Matrix Dermatology Eve Medical NIH – NIAID
3DBiopsy LLC Exact Imaging NIH – NIBIB
4P Therapeutics Expanding Orthopedics Inc. Nodexus Inc
4SC Discovery Expanesthetics Novateur Ventures Inc.
Ability Pharmaceuticals, SL Exzell Pharma Novodiax
AbViro LLC Fannin Innovation Studio Novodiax, Inc.
Access Vascular Fibralign Corporation NQ Oncology
Access Vascular First Island Capital NSIP LLC
AccuraGen Flanders Investment and Trade NVIGEN Inc.
Achaogen FluidDA Inc NX Develoment Corp
Acteris, inc FLUIDDA NV Obetat Biopharm
Actokine Therapeutics Foresee Pharmaceuticals Co., Ltd. Oculus Innovative Sciences
Addex Pharma Freeenome ODS Medical
Adenium Biotech FreeMind OncoSec Medical
Adjuvance Technologies FreeMind Group OncoSec Medical Inc
Admetsys Freenome Oneva
Aduro Biotech, Inc. Fusion Genomics Corporation Onxeo
Advanced Brain Monitoring, Inc. G2BP Pharma Inc Opexa Therapeutics
Advokatfirman Urban Olson AB Gamma Vaccines Orphidia
Affilogic Gene Predit Osborne Clarke
Aggio Sergeant Genentech Palo Alto Health Sciences
Agilvax GeNeuro Palobiofarma
AIMS Gershon MedTech Pherin Pharmaceuticals, Inc
Alaunus Biosciences Global BioDevelopment Philips Healthcare
Alfidi Capital Global Securities PhotoMed Technologies
ALGOMEDIX GlobalReach Business Solutions Pitango Venture Capital
Alpha Cancer Technologies Inc. GlycoMimetics, Inc. Planet Biotechnology Inc.
Alpha Omega LLC Go Far Advisors Planet Biotechnology.com
Alstem, LLC Go To Market Consulting PlasmaMedic
Alzeca Biosciences Goodwin Procter LLP POC Medical Systems
Amarit Biosciences, Inc Habit Design POC Medical Systems Inc.
AMBS Halteres Associates Portal Instruments, Inc
Anabios Corp Harvard Business School Portal Instruments, Inc.
Anergis Hawaii Biotech, Inc. Precision Image Analysis
Anida Pharma Inc. Health Anonymous, a Public Benefit Corporation Predictive Therapeutics
Annexon Biosciences Healthier Globe PreventAGE Health Care
Antiva Biosciences Helomics Corporation Prima BioMed
Antiva Biosciences, Inc. Helomics Corporation – Pittsburgh, Profusa
Arcturus Therapeutics Heraeus Profusa, Inc.
Arecor Heraeus Medical Progress LLP
Arisan Therapeutics Hercules Tech ProPharma Group
Arizona State University Hercules Technology Protagen AG
Armetheon Hercules Technology Growth Capital PsiOxus Therapeutics Ltd
Aronora, Inc. HIREtech Qilu Pharmaceuticals
Aschenbrenner Consulting HRD Partners Ltd Qrono Inc.
Atheneos Capital HudsonAlpha Institute for Biotechnology Quanta Fluid Solutions Ltd
Auritec Pharmaceutical Huntington Medical Research Institutes (HMRI) ReGena-Vet Laboratories, LLC
Auritec Pharmaceutical iClinical Inc Regenesance
Auritec Pharmaceuticals ICubate Representing KbioBox (Genomic Analysis and Design)
Autonomic Technologies Ignite Capital Partners, Inc. Resilience Therapeutics
Avacyn Pharmaceuticals, Inc. Image Analysis Respira Therapeutics, Inc.
Avails Medical, Inc. Imanova Limited Returnity
Avidity NanoMedicines Immune Biosolutions Revealix
Balinbac Therapeutics, Inc. Impleo Medical Revolution Contraceptives LLC
BBC, LLC InnaVirVax Riptide Bioscience
Beijing Augeas Consulting Group Innovation Endeavors RJS Consulting
Bell Biosystems, Inc. Invicta Medical SageMedic, Inc.
Benefunder i-Optics Sanaria Inc.
Bespoke Business Strategy Inc. Isomerase Therapeutics Ltd Sandia National Laboratories
Beta Cat Pharmaceuticals Jack Law Firm SCiH Advisory
BetaStem Therapeutics JAG Shaw Baker Sensoria, Inc
BethCare, Inc Jan Medical Sensorion SA
Biodesix, Inc. Janpix Ltd SGS Life Sciences
BioLab Services, LLC JPM-MCS Silkim Ltd. / Concenter bioPharma
Biologics Resources LLC KangarooHealth Inc. Simpatica Medicine
Biomatrica Katan Family Office SinSa Labs
Biomatrica Kurma Partners SinSa Labs Inc.
Bionor Pharma ASA Kymab Ltd SonderMind
Bionure Inc Lacerta Bio/Ventac Partners Sound Affects
BioPacific Investors LamdaGen Corp. Spectromics
Biothera Larta Institute SpotOn Sciences
Bioxiness Pharmaceuticals Latham Biopharm Group Spray Venture Partners
Boston University lawrence livermore national lab Stanford University
Brain Trust LeapYear Stanford University and GuidanceCue
BrainStem Biometrics, Inc. Life Science Nation StemBioSys
Business Development & Investor Relations Life Science Washington (WBBA) StemCElls, Inc.
BusStim-Business Stimulant Consultants Life Sciences Consulting Stemedica International SA
CancerVacs and AllergyVacs Lightlake Therapeutics Inc. Stemgenics
Candesant Biomedical Lilly Creek Vaccines Inc. STEMP Inc
catalent LiveLeaf Bioscience stiris research
Cell Care Therapeutics LLNL Strategic BioPharm
Chimerix Loxbridge Strekin  AG
CHO Plus, Inc. LumaMed Sustainable Sourcing Partners
Chromacode ManageUP PRM TAXIS Pharmaceuticals, Inc.
Chromocell Marina Biotech, Inc. the puguang investment holding group
Chromocell Coporation Massachusetts Life Sciences Center The Rockefeller University
CiToxLAB Maxim TheraBiol Inc
Clermont Partners Maxim Group LLC TheraBiol, Inc.
Click Nucleic Acids, Inc. MCKA company THGMW
Cloud Pharmaceuticals Med Qiao Group LLC Thrive Bioscience, Inc.
CMC Contrast AB MED1 Ventures tls
Cocoon Biotech Meda Biotech LLC TopgeniX
Codagenix Medicenna therapeutics inc ToxEM LLC
Codagenix, Inc. MediCoventures Trade Office of the French Embassy
Cofactor Genomics MedImmune TranScrip
Colby Medtep Transition Therapeutics
Colby Pharma Metabolomic Diagnostics Transparency Life Sciences, LLC
Congenica Metaclipse Therapeutics Transverse Medical Inc
Convergent R.N.R MGB Biopharma Ltd Travus Therapeutics
CorMedix Michael J. Fox Foundation Tuevol Therapeutics
Costanoan Biotechnologies Microbion UCSF
Coulter Partners Milestone Capital UCSF-Entrepreneurship Center
CPC Mill Valley Partners UNC-Chapel Hill
CPC Scientific Minerva Biotechnologies Universal Stabilization Technologies, Inc.
CrystalGenomics,Inc Mistubishi Tanabe Pharma Holdings America, Inc vaxess
Cukierman & Co. Life Sciences Mitsubishi Tanabe Pharma Vince & Associates Clinical Research
CureDuchenne Ventures Mitsubishi Tanabe Pharma Holdings America Inc. Virtual Beast Consulting
CureMetrix Molecula SA Visionary Pharmaceuticals
Cybelle Biosciences Molecular Assemblies Vitavis Laboratories, Inc.
Cyrano Therapeutics, Inc. MRCT Vogel BioC
DigiSight Technologies Nanobiotix Voiceitt
DURECT Corp. NANOBIOTIX US Washington Biotechnology & Biomedical Association
Eckert & Ziegler Radiopharma, Inc. Nantkwest WBBA
Eclosion2 NASC WCM Group
Edesa Biotech Inc. National Multiple Sclerosis Society Westbury Group
Elastagen Nelsen Biomedical Wit Creek Partners
Embera NeuroTherapeutics NeoVinci Health Xeris Pharmaceuticals, Inc
Embera NeuroTherapeutics, Inc. Neuraltus Pharmaceuticals Xeris Pharmaceuticals, Inc.
enano Neurolixis XOMA
Epiontis NeuroSave ZeroTo510 Medical Device Accelerator
NewCo Zumutor Biologics Inc.
Contact us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Questions, issues or concerns? I'd love to help you!

Click ENTER to chat